Melanoma TrialFinder

Melanoma Focus have recently introduced a range of new content to their new website, including the new Melanoma Stages and Treatment – Patient Guide (MPG) with lots of new resources for your patients including 4 explainer videos by Elaine Vickers on melanoma, immunotherapies, targeted therapies and T-VEC, animations to illustrate and describe sentinel lymph node biopsies and wellbeing information such as vitamin D, microbiome and fertility. They have launched a Melanoma TrialFinder; 2 versions – 1 for professionals and 1 for patients with information explaining clinical trials. Visit their new website: https://melanomafocus.org/  If you would like leaflets for your patient packs on the MPG and/or the Melanoma TrialFinder, please contact [email protected]

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article